These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 21492077)
1. Emerging therapeutic targets and agents for pancreatic cancer therapy--where are we and where we have to go? Sebens S; Kalthoff H Anticancer Agents Med Chem; 2011 Jun; 11(5):408-10. PubMed ID: 21492077 [No Abstract] [Full Text] [Related]
2. Targeting stroma in pancreatic cancer: Promises and failures of targeted therapies. Bahrami A; Khazaei M; Bagherieh F; Ghayour-Mobarhan M; Maftouh M; Hassanian SM; Avan A J Cell Physiol; 2017 Nov; 232(11):2931-2937. PubMed ID: 28083912 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic targeting in pancreatic cancer. van Kampen JG; Marijnissen-van Zanten MA; Simmer F; van der Graaf WT; Ligtenberg MJ; Nagtegaal ID Cancer Treat Rev; 2014 Jun; 40(5):656-64. PubMed ID: 24433955 [TBL] [Abstract][Full Text] [Related]
5. Targeted drug delivery systems for pancreatic cancer. Khare V; Alam N; Saneja A; Dubey RD; Gupta PN J Biomed Nanotechnol; 2014 Dec; 10(12):3462-82. PubMed ID: 26000366 [TBL] [Abstract][Full Text] [Related]
6. Reshaping the Tumor Stroma for Treatment of Pancreatic Cancer. Vennin C; Murphy KJ; Morton JP; Cox TR; Pajic M; Timpson P Gastroenterology; 2018 Mar; 154(4):820-838. PubMed ID: 29287624 [TBL] [Abstract][Full Text] [Related]
7. Crosstalk between stromal cells and cancer cells in pancreatic cancer: New insights into stromal biology. Zhan HX; Zhou B; Cheng YG; Xu JW; Wang L; Zhang GY; Hu SY Cancer Lett; 2017 Apr; 392():83-93. PubMed ID: 28189533 [TBL] [Abstract][Full Text] [Related]
8. Key role of pancreatic stellate cells in pancreatic cancer. Pothula SP; Xu Z; Goldstein D; Pirola RC; Wilson JS; Apte MV Cancer Lett; 2016 Oct; 381(1):194-200. PubMed ID: 26571462 [TBL] [Abstract][Full Text] [Related]
9. Neuropilin and neuropilin associated molecules as new molecular targets in pancreatic adenocarcinoma. Muders MH Anticancer Agents Med Chem; 2011 Jun; 11(5):442-7. PubMed ID: 21492075 [TBL] [Abstract][Full Text] [Related]
18. From targets to treatments: a review of molecular targets in pancreatic neuroendocrine tumors. Wiedenmann B; Pavel M; Kos-Kudla B Neuroendocrinology; 2011; 94(3):177-90. PubMed ID: 21893937 [TBL] [Abstract][Full Text] [Related]